Krystal Biotech Inc (KRYS)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 946,380 | 885,846 | 838,893 | 799,242 | 778,641 | 755,948 | 653,114 | 489,566 | 522,231 | 540,772 | 559,181 | 548,554 | 593,576 | 408,237 | 418,540 | 430,652 | 292,084 | 301,720 | 309,696 | 198,369 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $946,380K)
= 0.00
Krystal Biotech Inc has consistently maintained a debt-to-capital ratio of 0.00% across all reported periods from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt in its capital structure during these periods. A debt-to-capital ratio of 0.00% suggests that the company has financed its operations entirely through equity, which can be viewed favorably as it signifies a lower financial risk due to the absence of debt obligations. It also implies that the company has not taken advantage of leverage to amplify returns, which may result in lower potential profitability but also reduces financial risks associated with debt. Overall, the consistent 0.00% debt-to-capital ratio reflects Krystal Biotech's conservative capital structure and financial stability.
Peer comparison
Dec 31, 2024